Study Update: Bone Therapeutics’ Phase III Knee Trial

Bone Therapeutics completed recruitment and treated more than 700 patients in its pivotal Phase III clinical study with the JTA-004 viscosupplement in patients with knee osteoarthritis (OA).

First patients were treated in May 2020. Topline results are anticipated on the three-month primary endpoint and six-month follow-up period in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us